Walleye Capital LLC Cooper Companies, Inc. Transaction History

Walleye Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$306.88 - $380.0 $7.77 Million - $9.62 Million	-25,319 Reduced 74.52%	8,657 $3.28 Million
Q3 2023 Nov 14, 2023	BUY	$315.92 - $397.36 $2.96 Million - $3.72 Million	9,369 Added 38.07%	33,976 $10.8 Million
Q2 2023 Aug 14, 2023	SELL	$346.15 - $392.09 $1.42 Million - $1.61 Million	-4,102 Reduced 14.29%	24,607 $9.44 Million
Q1 2023 May 15, 2023	BUY	$323.56 - $373.36 $9.29 Million - $10.7 Million	28,709 New	28,709 $10.7 Million
Q2 2022 Aug 08, 2022	SELL	$301.4 - $428.42 $146,480 - $208,212	-486 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$379.46 - $424.54 $184,417 - $206,326	486 New	486 $203,000
Q2 2021 Aug 16, 2021	SELL	$372.36 - $412.07 $753,656 - $834,029	-2,024 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$357.26 - $392.57 $723,094 - $794,561	2,024 New	2,024 $777,000
Q4 2020 Feb 16, 2021	SELL	$319.05 - $363.32 $690,105 - $785,861	-2,163 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$280.08 - $347.78 $605,813 - $752,248	2,163 New	2,163 $729,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.